Despite the recent run up in pharma stocks, this week, problems related to the US FDA have made a come back. Jagdish Malkani, member at BSE and NSE believes though the Indian pharmaceuticals industry is a great play, investors should not get carried away with it.
first published: Sep 12, 2014 04:00 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

